Discover how scientists identified the core structural residues in the Bcl-2 protein family, a breakthrough with profound implications for cancer treatment.
Exploring the epigenetic mechanisms behind Bax silencing and Bcl-2 overexpression in neuroendocrine lung cancers and potential therapeutic approaches.